Deerfield Mgmt IV, L.P.
Director10% Owner

Deerfield Mgmt IV, L.P. insider trades: Larimar Therapeutics (LRMR) stock buys and sales

Director, Larimar Therapeutics Last trade Feb 27, 2026 31 Form 4 filings
$70.9M
Sold, last 12 months
2 sales
$25.0M
Bought, last 12 months
4 buys
48
Open-market trades
since 2018
16
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Deerfield Mgmt IV, L.P. reports to the SEC

and 10 more companies

Open-market buys and sales

48 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 27, 2026LRMR↑ Buy$10.0M
Feb 27, 2026LRMR↑ Buy$5.4M
Feb 27, 2026LRMR↑ Buy$5.4M
Feb 27, 2026LRMR↑ Buy$4.2M
Nov 24, 2025NUVL↓ Sell$35.4M
Nov 24, 2025NUVL↓ Sell$35.4M
Jul 31, 2025LRMR↑ Buy$10.8M
Jul 31, 2025LRMR↑ Buy$10.8M
Jul 31, 2025LRMR↑ Buy$8.3M
Jun 27, 2025SPRY↓ Sell$6.8M
Jun 27, 2025SPRY↓ Sell$6.8M
Nov 12, 2024SPRY↓ Sell$5.1M
Nov 12, 2024SPRY↓ Sell$5.1M
Oct 22, 2024NUVL↓ Sell$97.8M
Oct 22, 2024NUVL↓ Sell$97.8M
Mar 12, 2024AHCO↓ Sell$3.8M
Feb 16, 2024LRMR↑ Buy$12.5M
Feb 16, 2024LRMR↑ Buy$12.5M
Feb 16, 2024LRMR↑ Buy$12.5M
Nov 3, 2022NUVL↑ Buy$21.8M
Sep 16, 2022LRMR↑ Buy$8.7M
Sep 16, 2022LRMR↑ Buy$8.7M
Sep 16, 2022LRMR↑ Buy$8.7M
Sep 16, 2022LRMR↑ Buy$8.7M
Jun 6, 2022MIRM↓ Sell$505K
Jun 6, 2022MIRM↓ Sell$457K
Jul 9, 2021MIRM↓ Sell$1.6M
Jul 7, 2021MIRM↓ Sell$1.1M
Jun 30, 2021LRMR↑ Buy$2.0M
Jun 30, 2021LRMR↑ Buy$2.0M
Jun 30, 2021LRMR↑ Buy$2.0M
Jun 1, 2021OMIC↑ Buy$23.1M
Jun 1, 2021OMIC↑ Buy$9.9M
Mar 30, 2021EWTX↑ Buy$10.0M
Jul 28, 2020ANNX↑ Buy$6.0M
Jul 28, 2020ANNX↑ Buy$6.0M
Jul 14, 2020NKTX↑ Buy$9.0M
Jul 14, 2020NKTX↑ Buy$9.0M
Feb 18, 2020RVMD↑ Buy$5.1M
Feb 18, 2020RVMD↑ Buy$5.1M
Feb 10, 2020SDGR↑ Buy$4.3M
Oct 29, 2019CABA↑ Buy$7.7M
Oct 7, 2019FREQ↑ Buy$4.0M
Jul 22, 2019MIRM↑ Buy$2.5M
Jul 22, 2019MIRM↑ Buy$2.5M
Oct 1, 2018ARVN↑ Buy$1.7M
Oct 1, 2018ARVN↑ Buy$1.7M
Oct 1, 2018ARVN↑ Buy$1.7M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other LRMR insiders

Open-market trades in the last 12 months

About Deerfield Mgmt IV, L.P.'s insider trades

Deerfield Mgmt IV, L.P. is a director at Larimar Therapeutics (LRMR). Since Oct 1, 2018, it has reported 35 open-market purchases worth $264.3M and 13 sales worth $297.6M on SEC Form 4. In the last 12 months: 4 buys ($25.0M) and 2 sales ($70.9M).

Its filings also include conversions (12 filings), other transactions (7 filings), shares returned to the company (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LRMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.